MicrofluidX Demonstrate The Cyto Engine

Phacilitate
2 February 2023
SHARE NOW
ATW
Automation & Digitisation
Cell Therapy
Gene Therapy
Logistics
In this Tech Demo, James Kusena, Vice President of Bioprocessing and Applications at MicrofluidX, tells us about their core technology, The Cyto Engine, as seen at Advanced Therapies Week 2023. 

The Cyto Engine addresses the difficulties of translating, manufacturing and commercialising cell therapies in a cost effective manner.

James explains how this technology has demonstrated to offer superior process efficiency, repeatability and cell health.

This demo has been produced in partnership with MicrofluidX.